- Home
- HOMB vs CRNX Comparison
HOMB vs CRNX Comparison
Compare HOMB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOMB
- CRNX
- Stock Information
- Founded
- HOMB 1998
- CRNX 2008
- Country
- HOMB United States
- CRNX United States
- Employees
- HOMB N/A
- CRNX N/A
- Industry
- HOMB Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- HOMB Finance
- CRNX Health Care
- Exchange
- HOMB Nasdaq
- CRNX Nasdaq
- Market Cap
- HOMB 5.5B
- CRNX 5.2B
- IPO Year
- HOMB 2006
- CRNX 2018
- Fundamental
- Price
- HOMB $29.47
- CRNX $37.46
- Analyst Decision
- HOMB Buy
- CRNX Strong Buy
- Analyst Count
- HOMB 4
- CRNX 12
- Target Price
- HOMB $31.25
- CRNX $72.64
- AVG Volume (30 Days)
- HOMB 1.0M
- CRNX 747.4K
- Earning Date
- HOMB 04-17-2025
- CRNX 02-27-2025
- Dividend Yield
- HOMB 2.65%
- CRNX N/A
- EPS Growth
- HOMB 3.65
- CRNX N/A
- EPS
- HOMB 2.01
- CRNX N/A
- Revenue
- HOMB $969,278,000.00
- CRNX $1,038,999.00
- Revenue This Year
- HOMB N/A
- CRNX N/A
- Revenue Next Year
- HOMB $3.57
- CRNX $206.01
- P/E Ratio
- HOMB $14.66
- CRNX N/A
- Revenue Growth
- HOMB N/A
- CRNX N/A
- 52 Week Low
- HOMB $22.38
- CRNX $34.07
- 52 Week High
- HOMB $32.91
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- HOMB 43.68
- CRNX 42.29
- Support Level
- HOMB $30.26
- CRNX $35.10
- Resistance Level
- HOMB $30.70
- CRNX $35.85
- Average True Range (ATR)
- HOMB 0.66
- CRNX 1.45
- MACD
- HOMB -0.16
- CRNX 0.47
- Stochastic Oscillator
- HOMB 8.63
- CRNX 49.78
About HOMB Home BancShares Inc.
Home BancShares Inc is a bank holding company that operates through its wholly owned community bank subsidiary, Centennial Bank. The bank provides a broad range of commercial and retail banking, as well as related financial services, to a diverse customer base. Its customer base includes businesses, real estate developers and investors, individuals, and municipalities. The company's loan portfolio, while diversified, is typically between half and two thirds in commercial real estate loans. The company's plan emphasizes growth, both through strategic acquisitions and organically within its existing markets. The bank also emphasizes attracting experienced bankers, credit quality, and a solid balance sheet. The bank's main source of net revenue is net interest income.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.